- Home
- USAC vs CNTA Comparison
USAC vs CNTA Comparison
Compare USAC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | USAC | CNTA |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | USAC | CNTA |
|---|---|---|
| Price | $27.65 | $26.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $26.75 | ★ $39.50 |
| AVG Volume (30 Days) | 187.3K | ★ 1.0M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $698,365,000.00 | N/A |
| Revenue This Year | $26.04 | N/A |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | $31.25 | ★ N/A |
| Revenue Growth | ★ 19.51 | N/A |
| 52 Week Low | $21.59 | $9.60 |
| 52 Week High | $28.09 | $30.58 |
Technical Indicators
Market Signals| Indicator | USAC | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 66.05 | 62.40 |
| Support Level | $22.62 | $21.93 |
| Resistance Level | N/A | $30.29 |
| Average True Range (ATR) | 0.75 | 1.11 |
| MACD | 0.04 | 0.26 |
| Stochastic Oscillator | 97.21 | 80.04 |
Price Performance
Historical ComparisonAbout USAC USA Compression Partners LP
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.